Global Hematopoietic Stem Cells (HSCs) Market Insights, Forecast to 2029
This report presents an overview of global market for Hematopoietic Stem Cells (HSCs) market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Hematopoietic Stem Cells (HSCs), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hematopoietic Stem Cells (HSCs), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hematopoietic Stem Cells (HSCs) revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Hematopoietic Stem Cells (HSCs) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Hematopoietic Stem Cells (HSCs) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd. and TiGenix N.V., etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Hematopoietic Stem Cells (HSCs) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematopoietic Stem Cells (HSCs) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hematopoietic Stem Cells (HSCs) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Hematopoietic Stem Cells (HSCs), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hematopoietic Stem Cells (HSCs), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hematopoietic Stem Cells (HSCs) revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Hematopoietic Stem Cells (HSCs) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Hematopoietic Stem Cells (HSCs) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd. and TiGenix N.V., etc.
By Company
- Kite Pharma Inc.
- Thermo Fisher Scientific
- PromoCell
- CellGenix Technologie Transfer GmbH
- Cesca Therapeutics Inc.
- R&D Systems
- Genlantis
- Lonza Group Ltd.
- TiGenix N.V.
- ScienCell Research Laboratories
- China Cord Blood Corporation
- Vcanbio
- Boyalife
- Beike Biotechnology
- Leukocyte
- Lymphocytes
- Red Blood Cells
- Platelets
- Blood System Diseases
- Autoimmune Diseases
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Hematopoietic Stem Cells (HSCs) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematopoietic Stem Cells (HSCs) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hematopoietic Stem Cells (HSCs) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Leukocyte
1.2.3 Lymphocytes
1.2.4 Red Blood Cells
1.2.5 Platelets
1.3 Market by Application
1.3.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Blood System Diseases
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Hematopoietic Stem Cells (HSCs) Market Perspective (2018-2029)
2.2 Global Hematopoietic Stem Cells (HSCs) Growth Trends by Region
2.2.1 Hematopoietic Stem Cells (HSCs) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hematopoietic Stem Cells (HSCs) Historic Market Size by Region (2018-2023)
2.2.3 Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Region (2024-2029)
2.3 Hematopoietic Stem Cells (HSCs) Market Dynamics
2.3.1 Hematopoietic Stem Cells (HSCs) Industry Trends
2.3.2 Hematopoietic Stem Cells (HSCs) Market Drivers
2.3.3 Hematopoietic Stem Cells (HSCs) Market Challenges
2.3.4 Hematopoietic Stem Cells (HSCs) Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Hematopoietic Stem Cells (HSCs) by Players
3.1.1 Global Hematopoietic Stem Cells (HSCs) Revenue by Players (2018-2023)
3.1.2 Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Players (2018-2023)
3.2 Global Hematopoietic Stem Cells (HSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hematopoietic Stem Cells (HSCs), Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio
3.4.1 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematopoietic Stem Cells (HSCs) Revenue in 2022
3.5 Global Key Players of Hematopoietic Stem Cells (HSCs) Head office and Area Served
3.6 Global Key Players of Hematopoietic Stem Cells (HSCs), Product and Application
3.7 Global Key Players of Hematopoietic Stem Cells (HSCs), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HEMATOPOIETIC STEM CELLS (HSCS) BREAKDOWN DATA BY TYPE
4.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Type (2018-2023)
4.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2024-2029)
5 HEMATOPOIETIC STEM CELLS (HSCS) BREAKDOWN DATA BY APPLICATION
5.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Application (2018-2023)
5.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
6.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Type
6.2.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023)
6.2.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029)
6.2.3 North America Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
6.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Application
6.3.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023)
6.3.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029)
6.3.3 North America Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
6.4 North America Hematopoietic Stem Cells (HSCs) Market Size by Country
6.4.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023)
6.4.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
7.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type
7.2.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023)
7.2.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029)
7.2.3 Europe Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
7.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application
7.3.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023)
7.3.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029)
7.3.3 Europe Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
7.4 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country
7.4.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023)
7.4.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
8.2 China Hematopoietic Stem Cells (HSCs) Market Size by Type
8.2.1 China Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023)
8.2.2 China Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029)
8.2.3 China Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
8.3 China Hematopoietic Stem Cells (HSCs) Market Size by Application
8.3.1 China Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023)
8.3.2 China Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029)
8.3.3 China Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
9.2 Asia Hematopoietic Stem Cells (HSCs) Market Size by Type
9.2.1 Asia Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023)
9.2.2 Asia Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029)
9.2.3 Asia Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
9.3 Asia Hematopoietic Stem Cells (HSCs) Market Size by Application
9.3.1 Asia Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023)
9.3.2 Asia Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029)
9.3.3 Asia Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
9.4 Asia Hematopoietic Stem Cells (HSCs) Market Size by Region
9.4.1 Asia Hematopoietic Stem Cells (HSCs) Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Hematopoietic Stem Cells (HSCs) Market Size by Region (2018-2023)
9.4.3 Asia Hematopoietic Stem Cells (HSCs) Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Kite Pharma Inc.
11.1.1 Kite Pharma Inc. Company Details
11.1.2 Kite Pharma Inc. Business Overview
11.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Introduction
11.1.4 Kite Pharma Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.1.5 Kite Pharma Inc. Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 PromoCell
11.3.1 PromoCell Company Details
11.3.2 PromoCell Business Overview
11.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Introduction
11.3.4 PromoCell Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.3.5 PromoCell Recent Developments
11.4 CellGenix Technologie Transfer GmbH
11.4.1 CellGenix Technologie Transfer GmbH Company Details
11.4.2 CellGenix Technologie Transfer GmbH Business Overview
11.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Introduction
11.4.4 CellGenix Technologie Transfer GmbH Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.4.5 CellGenix Technologie Transfer GmbH Recent Developments
11.5 Cesca Therapeutics Inc.
11.5.1 Cesca Therapeutics Inc. Company Details
11.5.2 Cesca Therapeutics Inc. Business Overview
11.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Introduction
11.5.4 Cesca Therapeutics Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.5.5 Cesca Therapeutics Inc. Recent Developments
11.6 R&D Systems
11.6.1 R&D Systems Company Details
11.6.2 R&D Systems Business Overview
11.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Introduction
11.6.4 R&D Systems Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.6.5 R&D Systems Recent Developments
11.7 Genlantis
11.7.1 Genlantis Company Details
11.7.2 Genlantis Business Overview
11.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Introduction
11.7.4 Genlantis Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.7.5 Genlantis Recent Developments
11.8 Lonza Group Ltd.
11.8.1 Lonza Group Ltd. Company Details
11.8.2 Lonza Group Ltd. Business Overview
11.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Introduction
11.8.4 Lonza Group Ltd. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.8.5 Lonza Group Ltd. Recent Developments
11.9 TiGenix N.V.
11.9.1 TiGenix N.V. Company Details
11.9.2 TiGenix N.V. Business Overview
11.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Introduction
11.9.4 TiGenix N.V. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.9.5 TiGenix N.V. Recent Developments
11.10 ScienCell Research Laboratories
11.10.1 ScienCell Research Laboratories Company Details
11.10.2 ScienCell Research Laboratories Business Overview
11.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Introduction
11.10.4 ScienCell Research Laboratories Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.10.5 ScienCell Research Laboratories Recent Developments
11.11 China Cord Blood Corporation
11.11.1 China Cord Blood Corporation Company Details
11.11.2 China Cord Blood Corporation Business Overview
11.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Introduction
11.11.4 China Cord Blood Corporation Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.11.5 China Cord Blood Corporation Recent Developments
11.12 Vcanbio
11.12.1 Vcanbio Company Details
11.12.2 Vcanbio Business Overview
11.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Introduction
11.12.4 Vcanbio Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.12.5 Vcanbio Recent Developments
11.13 Boyalife
11.13.1 Boyalife Company Details
11.13.2 Boyalife Business Overview
11.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Introduction
11.13.4 Boyalife Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.13.5 Boyalife Recent Developments
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Details
11.14.2 Beike Biotechnology Business Overview
11.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Introduction
11.14.4 Beike Biotechnology Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.14.5 Beike Biotechnology Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Leukocyte
1.2.3 Lymphocytes
1.2.4 Red Blood Cells
1.2.5 Platelets
1.3 Market by Application
1.3.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Blood System Diseases
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Hematopoietic Stem Cells (HSCs) Market Perspective (2018-2029)
2.2 Global Hematopoietic Stem Cells (HSCs) Growth Trends by Region
2.2.1 Hematopoietic Stem Cells (HSCs) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hematopoietic Stem Cells (HSCs) Historic Market Size by Region (2018-2023)
2.2.3 Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Region (2024-2029)
2.3 Hematopoietic Stem Cells (HSCs) Market Dynamics
2.3.1 Hematopoietic Stem Cells (HSCs) Industry Trends
2.3.2 Hematopoietic Stem Cells (HSCs) Market Drivers
2.3.3 Hematopoietic Stem Cells (HSCs) Market Challenges
2.3.4 Hematopoietic Stem Cells (HSCs) Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Hematopoietic Stem Cells (HSCs) by Players
3.1.1 Global Hematopoietic Stem Cells (HSCs) Revenue by Players (2018-2023)
3.1.2 Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Players (2018-2023)
3.2 Global Hematopoietic Stem Cells (HSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hematopoietic Stem Cells (HSCs), Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio
3.4.1 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematopoietic Stem Cells (HSCs) Revenue in 2022
3.5 Global Key Players of Hematopoietic Stem Cells (HSCs) Head office and Area Served
3.6 Global Key Players of Hematopoietic Stem Cells (HSCs), Product and Application
3.7 Global Key Players of Hematopoietic Stem Cells (HSCs), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HEMATOPOIETIC STEM CELLS (HSCS) BREAKDOWN DATA BY TYPE
4.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Type (2018-2023)
4.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2024-2029)
5 HEMATOPOIETIC STEM CELLS (HSCS) BREAKDOWN DATA BY APPLICATION
5.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Application (2018-2023)
5.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
6.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Type
6.2.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023)
6.2.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029)
6.2.3 North America Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
6.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Application
6.3.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023)
6.3.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029)
6.3.3 North America Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
6.4 North America Hematopoietic Stem Cells (HSCs) Market Size by Country
6.4.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023)
6.4.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
7.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type
7.2.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023)
7.2.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029)
7.2.3 Europe Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
7.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application
7.3.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023)
7.3.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029)
7.3.3 Europe Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
7.4 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country
7.4.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023)
7.4.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
8.2 China Hematopoietic Stem Cells (HSCs) Market Size by Type
8.2.1 China Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023)
8.2.2 China Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029)
8.2.3 China Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
8.3 China Hematopoietic Stem Cells (HSCs) Market Size by Application
8.3.1 China Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023)
8.3.2 China Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029)
8.3.3 China Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
9.2 Asia Hematopoietic Stem Cells (HSCs) Market Size by Type
9.2.1 Asia Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023)
9.2.2 Asia Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029)
9.2.3 Asia Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
9.3 Asia Hematopoietic Stem Cells (HSCs) Market Size by Application
9.3.1 Asia Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023)
9.3.2 Asia Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029)
9.3.3 Asia Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
9.4 Asia Hematopoietic Stem Cells (HSCs) Market Size by Region
9.4.1 Asia Hematopoietic Stem Cells (HSCs) Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Hematopoietic Stem Cells (HSCs) Market Size by Region (2018-2023)
9.4.3 Asia Hematopoietic Stem Cells (HSCs) Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Kite Pharma Inc.
11.1.1 Kite Pharma Inc. Company Details
11.1.2 Kite Pharma Inc. Business Overview
11.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Introduction
11.1.4 Kite Pharma Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.1.5 Kite Pharma Inc. Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 PromoCell
11.3.1 PromoCell Company Details
11.3.2 PromoCell Business Overview
11.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Introduction
11.3.4 PromoCell Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.3.5 PromoCell Recent Developments
11.4 CellGenix Technologie Transfer GmbH
11.4.1 CellGenix Technologie Transfer GmbH Company Details
11.4.2 CellGenix Technologie Transfer GmbH Business Overview
11.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Introduction
11.4.4 CellGenix Technologie Transfer GmbH Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.4.5 CellGenix Technologie Transfer GmbH Recent Developments
11.5 Cesca Therapeutics Inc.
11.5.1 Cesca Therapeutics Inc. Company Details
11.5.2 Cesca Therapeutics Inc. Business Overview
11.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Introduction
11.5.4 Cesca Therapeutics Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.5.5 Cesca Therapeutics Inc. Recent Developments
11.6 R&D Systems
11.6.1 R&D Systems Company Details
11.6.2 R&D Systems Business Overview
11.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Introduction
11.6.4 R&D Systems Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.6.5 R&D Systems Recent Developments
11.7 Genlantis
11.7.1 Genlantis Company Details
11.7.2 Genlantis Business Overview
11.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Introduction
11.7.4 Genlantis Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.7.5 Genlantis Recent Developments
11.8 Lonza Group Ltd.
11.8.1 Lonza Group Ltd. Company Details
11.8.2 Lonza Group Ltd. Business Overview
11.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Introduction
11.8.4 Lonza Group Ltd. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.8.5 Lonza Group Ltd. Recent Developments
11.9 TiGenix N.V.
11.9.1 TiGenix N.V. Company Details
11.9.2 TiGenix N.V. Business Overview
11.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Introduction
11.9.4 TiGenix N.V. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.9.5 TiGenix N.V. Recent Developments
11.10 ScienCell Research Laboratories
11.10.1 ScienCell Research Laboratories Company Details
11.10.2 ScienCell Research Laboratories Business Overview
11.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Introduction
11.10.4 ScienCell Research Laboratories Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.10.5 ScienCell Research Laboratories Recent Developments
11.11 China Cord Blood Corporation
11.11.1 China Cord Blood Corporation Company Details
11.11.2 China Cord Blood Corporation Business Overview
11.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Introduction
11.11.4 China Cord Blood Corporation Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.11.5 China Cord Blood Corporation Recent Developments
11.12 Vcanbio
11.12.1 Vcanbio Company Details
11.12.2 Vcanbio Business Overview
11.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Introduction
11.12.4 Vcanbio Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.12.5 Vcanbio Recent Developments
11.13 Boyalife
11.13.1 Boyalife Company Details
11.13.2 Boyalife Business Overview
11.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Introduction
11.13.4 Boyalife Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.13.5 Boyalife Recent Developments
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Details
11.14.2 Beike Biotechnology Business Overview
11.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Introduction
11.14.4 Beike Biotechnology Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
11.14.5 Beike Biotechnology Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Leukocyte
Table 3. Key Players of Lymphocytes
Table 4. Key Players of Red Blood Cells
Table 5. Key Players of Platelets
Table 6. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Hematopoietic Stem Cells (HSCs) Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Hematopoietic Stem Cells (HSCs) Market Share by Region (2018-2023)
Table 10. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Hematopoietic Stem Cells (HSCs) Market Share by Region (2024-2029)
Table 12. Hematopoietic Stem Cells (HSCs) Market Trends
Table 13. Hematopoietic Stem Cells (HSCs) Market Drivers
Table 14. Hematopoietic Stem Cells (HSCs) Market Challenges
Table 15. Hematopoietic Stem Cells (HSCs) Market Restraints
Table 16. Global Hematopoietic Stem Cells (HSCs) Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Players (2018-2023)
Table 18. Global Top Hematopoietic Stem Cells (HSCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2022)
Table 19. Global Hematopoietic Stem Cells (HSCs) Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Hematopoietic Stem Cells (HSCs), Headquarters and Area Served
Table 22. Global Key Players of Hematopoietic Stem Cells (HSCs), Product and Application
Table 23. Global Key Players of Hematopoietic Stem Cells (HSCs), Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2018-2023)
Table 27. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2024-2029)
Table 29. Global Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Application (2018-2023)
Table 31. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Application (2024-2029)
Table 33. North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Hematopoietic Stem Cells (HSCs) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Hematopoietic Stem Cells (HSCs) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Hematopoietic Stem Cells (HSCs) Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Hematopoietic Stem Cells (HSCs) Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Hematopoietic Stem Cells (HSCs) Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029) & (US$ Million)
Table 65. Kite Pharma Inc. Company Details
Table 66. Kite Pharma Inc. Business Overview
Table 67. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Product
Table 68. Kite Pharma Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 69. Kite Pharma Inc. Recent Developments
Table 70. Thermo Fisher Scientific Company Details
Table 71. Thermo Fisher Scientific Business Overview
Table 72. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product
Table 73. Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 74. Thermo Fisher Scientific Recent Developments
Table 75. PromoCell Company Details
Table 76. PromoCell Business Overview
Table 77. PromoCell Hematopoietic Stem Cells (HSCs) Product
Table 78. PromoCell Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 79. PromoCell Recent Developments
Table 80. CellGenix Technologie Transfer GmbH Company Details
Table 81. CellGenix Technologie Transfer GmbH Business Overview
Table 82. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product
Table 83. CellGenix Technologie Transfer GmbH Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 84. CellGenix Technologie Transfer GmbH Recent Developments
Table 85. Cesca Therapeutics Inc. Company Details
Table 86. Cesca Therapeutics Inc. Business Overview
Table 87. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Product
Table 88. Cesca Therapeutics Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 89. Cesca Therapeutics Inc. Recent Developments
Table 90. R&D Systems Company Details
Table 91. R&D Systems Business Overview
Table 92. R&D Systems Hematopoietic Stem Cells (HSCs) Product
Table 93. R&D Systems Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 94. R&D Systems Recent Developments
Table 95. Genlantis Company Details
Table 96. Genlantis Business Overview
Table 97. Genlantis Hematopoietic Stem Cells (HSCs) Product
Table 98. Genlantis Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 99. Genlantis Recent Developments
Table 100. Lonza Group Ltd. Company Details
Table 101. Lonza Group Ltd. Business Overview
Table 102. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Product
Table 103. Lonza Group Ltd. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 104. Lonza Group Ltd. Recent Developments
Table 105. TiGenix N.V. Company Details
Table 106. TiGenix N.V. Business Overview
Table 107. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Product
Table 108. TiGenix N.V. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 109. TiGenix N.V. Recent Developments
Table 110. ScienCell Research Laboratories Company Details
Table 111. ScienCell Research Laboratories Business Overview
Table 112. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product
Table 113. ScienCell Research Laboratories Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 114. ScienCell Research Laboratories Recent Developments
Table 115. China Cord Blood Corporation Company Details
Table 116. China Cord Blood Corporation Business Overview
Table 117. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product
Table 118. China Cord Blood Corporation Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 119. China Cord Blood Corporation Recent Developments
Table 120. Vcanbio Company Details
Table 121. Vcanbio Business Overview
Table 122. Vcanbio Hematopoietic Stem Cells (HSCs) Product
Table 123. Vcanbio Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 124. Vcanbio Recent Developments
Table 125. Boyalife Company Details
Table 126. Boyalife Business Overview
Table 127. Boyalife Hematopoietic Stem Cells (HSCs) Product
Table 128. Boyalife Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 129. Boyalife Recent Developments
Table 130. Beike Biotechnology Company Details
Table 131. Beike Biotechnology Business Overview
Table 132. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product
Table 133. Beike Biotechnology Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 134. Beike Biotechnology Recent Developments
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 1. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Leukocyte
Table 3. Key Players of Lymphocytes
Table 4. Key Players of Red Blood Cells
Table 5. Key Players of Platelets
Table 6. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Hematopoietic Stem Cells (HSCs) Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Hematopoietic Stem Cells (HSCs) Market Share by Region (2018-2023)
Table 10. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Hematopoietic Stem Cells (HSCs) Market Share by Region (2024-2029)
Table 12. Hematopoietic Stem Cells (HSCs) Market Trends
Table 13. Hematopoietic Stem Cells (HSCs) Market Drivers
Table 14. Hematopoietic Stem Cells (HSCs) Market Challenges
Table 15. Hematopoietic Stem Cells (HSCs) Market Restraints
Table 16. Global Hematopoietic Stem Cells (HSCs) Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Players (2018-2023)
Table 18. Global Top Hematopoietic Stem Cells (HSCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2022)
Table 19. Global Hematopoietic Stem Cells (HSCs) Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Hematopoietic Stem Cells (HSCs), Headquarters and Area Served
Table 22. Global Key Players of Hematopoietic Stem Cells (HSCs), Product and Application
Table 23. Global Key Players of Hematopoietic Stem Cells (HSCs), Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2018-2023)
Table 27. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2024-2029)
Table 29. Global Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Application (2018-2023)
Table 31. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Application (2024-2029)
Table 33. North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Hematopoietic Stem Cells (HSCs) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Hematopoietic Stem Cells (HSCs) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Hematopoietic Stem Cells (HSCs) Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Hematopoietic Stem Cells (HSCs) Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Hematopoietic Stem Cells (HSCs) Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2024-2029) & (US$ Million)
Table 65. Kite Pharma Inc. Company Details
Table 66. Kite Pharma Inc. Business Overview
Table 67. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Product
Table 68. Kite Pharma Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 69. Kite Pharma Inc. Recent Developments
Table 70. Thermo Fisher Scientific Company Details
Table 71. Thermo Fisher Scientific Business Overview
Table 72. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product
Table 73. Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 74. Thermo Fisher Scientific Recent Developments
Table 75. PromoCell Company Details
Table 76. PromoCell Business Overview
Table 77. PromoCell Hematopoietic Stem Cells (HSCs) Product
Table 78. PromoCell Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 79. PromoCell Recent Developments
Table 80. CellGenix Technologie Transfer GmbH Company Details
Table 81. CellGenix Technologie Transfer GmbH Business Overview
Table 82. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product
Table 83. CellGenix Technologie Transfer GmbH Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 84. CellGenix Technologie Transfer GmbH Recent Developments
Table 85. Cesca Therapeutics Inc. Company Details
Table 86. Cesca Therapeutics Inc. Business Overview
Table 87. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Product
Table 88. Cesca Therapeutics Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 89. Cesca Therapeutics Inc. Recent Developments
Table 90. R&D Systems Company Details
Table 91. R&D Systems Business Overview
Table 92. R&D Systems Hematopoietic Stem Cells (HSCs) Product
Table 93. R&D Systems Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 94. R&D Systems Recent Developments
Table 95. Genlantis Company Details
Table 96. Genlantis Business Overview
Table 97. Genlantis Hematopoietic Stem Cells (HSCs) Product
Table 98. Genlantis Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 99. Genlantis Recent Developments
Table 100. Lonza Group Ltd. Company Details
Table 101. Lonza Group Ltd. Business Overview
Table 102. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Product
Table 103. Lonza Group Ltd. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 104. Lonza Group Ltd. Recent Developments
Table 105. TiGenix N.V. Company Details
Table 106. TiGenix N.V. Business Overview
Table 107. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Product
Table 108. TiGenix N.V. Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 109. TiGenix N.V. Recent Developments
Table 110. ScienCell Research Laboratories Company Details
Table 111. ScienCell Research Laboratories Business Overview
Table 112. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product
Table 113. ScienCell Research Laboratories Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 114. ScienCell Research Laboratories Recent Developments
Table 115. China Cord Blood Corporation Company Details
Table 116. China Cord Blood Corporation Business Overview
Table 117. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product
Table 118. China Cord Blood Corporation Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 119. China Cord Blood Corporation Recent Developments
Table 120. Vcanbio Company Details
Table 121. Vcanbio Business Overview
Table 122. Vcanbio Hematopoietic Stem Cells (HSCs) Product
Table 123. Vcanbio Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 124. Vcanbio Recent Developments
Table 125. Boyalife Company Details
Table 126. Boyalife Business Overview
Table 127. Boyalife Hematopoietic Stem Cells (HSCs) Product
Table 128. Boyalife Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 129. Boyalife Recent Developments
Table 130. Beike Biotechnology Company Details
Table 131. Beike Biotechnology Business Overview
Table 132. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product
Table 133. Beike Biotechnology Revenue in Hematopoietic Stem Cells (HSCs) Business (2018-2023) & (US$ Million)
Table 134. Beike Biotechnology Recent Developments
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Hematopoietic Stem Cells (HSCs) Market Share by Type: 2022 VS 2029
Figure 3. Leukocyte Features
Figure 4. Lymphocytes Features
Figure 5. Red Blood Cells Features
Figure 6. Platelets Features
Figure 7. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Hematopoietic Stem Cells (HSCs) Market Share by Application: 2022 VS 2029
Figure 9. Blood System Diseases Case Studies
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Other Case Studies
Figure 12. Hematopoietic Stem Cells (HSCs) Report Years Considered
Figure 13. Global Hematopoietic Stem Cells (HSCs) Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Hematopoietic Stem Cells (HSCs) Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Hematopoietic Stem Cells (HSCs) Market Share by Region: 2022 VS 2029
Figure 16. Global Hematopoietic Stem Cells (HSCs) Market Share by Players in 2022
Figure 17. Global Top Hematopoietic Stem Cells (HSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue in 2022
Figure 19. North America Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
Figure 21. North America Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
Figure 22. North America Hematopoietic Stem Cells (HSCs) Market Share by Country (2018-2029)
Figure 23. United States Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Hematopoietic Stem Cells (HSCs) Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
Figure 27. Europe Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
Figure 28. Europe Hematopoietic Stem Cells (HSCs) Market Share by Country (2018-2029)
Figure 29. Germany Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Hematopoietic Stem Cells (HSCs) Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
Figure 37. China Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
Figure 38. Asia Hematopoietic Stem Cells (HSCs) Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
Figure 40. Asia Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
Figure 41. Asia Hematopoietic Stem Cells (HSCs) Market Share by Region (2018-2029)
Figure 42. Japan Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Share by Country (2018-2029)
Figure 52. Brazil Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Kite Pharma Inc. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 60. PromoCell Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 61. CellGenix Technologie Transfer GmbH Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 62. Cesca Therapeutics Inc. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 63. R&D Systems Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 64. Genlantis Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 65. Lonza Group Ltd. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 66. TiGenix N.V. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 67. ScienCell Research Laboratories Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 68. China Cord Blood Corporation Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 69. Vcanbio Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 70. Boyalife Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 71. Beike Biotechnology Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Figure 1. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Hematopoietic Stem Cells (HSCs) Market Share by Type: 2022 VS 2029
Figure 3. Leukocyte Features
Figure 4. Lymphocytes Features
Figure 5. Red Blood Cells Features
Figure 6. Platelets Features
Figure 7. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Hematopoietic Stem Cells (HSCs) Market Share by Application: 2022 VS 2029
Figure 9. Blood System Diseases Case Studies
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Other Case Studies
Figure 12. Hematopoietic Stem Cells (HSCs) Report Years Considered
Figure 13. Global Hematopoietic Stem Cells (HSCs) Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Hematopoietic Stem Cells (HSCs) Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Hematopoietic Stem Cells (HSCs) Market Share by Region: 2022 VS 2029
Figure 16. Global Hematopoietic Stem Cells (HSCs) Market Share by Players in 2022
Figure 17. Global Top Hematopoietic Stem Cells (HSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue in 2022
Figure 19. North America Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
Figure 21. North America Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
Figure 22. North America Hematopoietic Stem Cells (HSCs) Market Share by Country (2018-2029)
Figure 23. United States Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Hematopoietic Stem Cells (HSCs) Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
Figure 27. Europe Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
Figure 28. Europe Hematopoietic Stem Cells (HSCs) Market Share by Country (2018-2029)
Figure 29. Germany Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Hematopoietic Stem Cells (HSCs) Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
Figure 37. China Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
Figure 38. Asia Hematopoietic Stem Cells (HSCs) Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
Figure 40. Asia Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
Figure 41. Asia Hematopoietic Stem Cells (HSCs) Market Share by Region (2018-2029)
Figure 42. Japan Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Hematopoietic Stem Cells (HSCs) Market Share by Country (2018-2029)
Figure 52. Brazil Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Kite Pharma Inc. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 60. PromoCell Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 61. CellGenix Technologie Transfer GmbH Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 62. Cesca Therapeutics Inc. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 63. R&D Systems Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 64. Genlantis Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 65. Lonza Group Ltd. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 66. TiGenix N.V. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 67. ScienCell Research Laboratories Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 68. China Cord Blood Corporation Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 69. Vcanbio Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 70. Boyalife Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 71. Beike Biotechnology Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
